138 related articles for article (PubMed ID: 16616577)
1. Positive cooperativity in the cellular uptake of a boronated porphyrin.
Novick S; Laster B; Quastel MR
Int J Biochem Cell Biol; 2006; 38(8):1374-81. PubMed ID: 16616577
[TBL] [Abstract][Full Text] [Related]
2. Biodistribution of boron compounds in an animal model of human undifferentiated thyroid cancer for boron neutron capture therapy.
Dagrosa MA; Viaggi M; Rebagliati RJ; Batistoni D; Kahl SB; Juvenal GJ; Pisarev MA
Mol Pharm; 2005; 2(2):151-6. PubMed ID: 15804189
[TBL] [Abstract][Full Text] [Related]
3. Boronated protoporphyrin (BOPP): localization in lysosomes of the human glioma cell line SF-767 with uptake modulated by lipoprotein levels.
Callahan DE; Forte TM; Afzal SM; Deen DF; Kahl SB; Bjornstad KA; Bauer WF; Blakely EA
Int J Radiat Oncol Biol Phys; 1999 Oct; 45(3):761-71. PubMed ID: 10524433
[TBL] [Abstract][Full Text] [Related]
4. Biological efficacy of boronated low-density lipoprotein for boron neutron capture therapy as measured in cell culture.
Laster BH; Kahl SB; Popenoe EA; Pate DW; Fairchild RG
Cancer Res; 1991 Sep; 51(17):4588-93. PubMed ID: 1873803
[TBL] [Abstract][Full Text] [Related]
5. Intracellular uptake of a new boronated porphyrin EC032.
Tsurubuchi T; Yamamoto T; Nakai K; Zaboronok A; Yoshida F; Miyakawa M; Shirakawa M; Yamamoto Y; Matsuda M; Matsumura A
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S94-6. PubMed ID: 19410469
[TBL] [Abstract][Full Text] [Related]
6. Receptor-targeted liposomal delivery of boron-containing cholesterol mimics for boron neutron capture therapy (BNCT).
Thirumamagal BT; Zhao XB; Bandyopadhyaya AK; Naranyanasamy S; Johnsamuel J; Tiwari R; Golightly DW; Patel V; Jehning BT; Backer MV; Barth RF; Lee RJ; Backer JM; Tjarks W
Bioconjug Chem; 2006; 17(5):1141-50. PubMed ID: 16984121
[TBL] [Abstract][Full Text] [Related]
7. Boron neutron capture therapy for undifferentiated thyroid carcinoma: preliminary results with the combined use of BPA and BOPP.
Viaggi M; Dagrosa MA; Longhino J; Blaumann H; Calzetta O; Kahl SB; Juvenal GJ; Pisarev MA
Appl Radiat Isot; 2004 Nov; 61(5):905-9. PubMed ID: 15308166
[TBL] [Abstract][Full Text] [Related]
8. Toxicity, biodistribution, and convection-enhanced delivery of the boronated porphyrin BOPP in the 9L intracerebral rat glioma model.
Ozawa T; Afzal J; Lamborn KR; Bollen AW; Bauer WF; Koo MS; Kahl SB; Deen DF
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):247-52. PubMed ID: 16111595
[TBL] [Abstract][Full Text] [Related]
9. A novel boronated-porphyrin as a radio-sensitizing agent for boron neutron capture therapy of tumours: in vitro and in vivo studies.
Jori G; Soncin M; Friso E; Vicente MG; Hao E; Miotto G; Colautti P; Moro D; Esposito J; Rosi G; Nava E; Sotti G; Fabris C
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S321-4. PubMed ID: 19376726
[TBL] [Abstract][Full Text] [Related]
10. Receptor dependent cellular uptake of synthetic low density lipoprotein by mammalian cells in serum-free tissue culture.
Hayavi S; Baillie G; Owens MD; Halbert GW
J Pharm Pharmacol; 2006 Oct; 58(10):1337-42. PubMed ID: 17034656
[TBL] [Abstract][Full Text] [Related]
11. [Boron neutron capture therapy applied to undifferentiated thyroid carcinoma].
Pisarev MA; Dagrosa MA; Thomasz L; Juvenal G
Medicina (B Aires); 2006; 66(6):569-73. PubMed ID: 17240633
[TBL] [Abstract][Full Text] [Related]
12. Total syntheses of three copper (II) tetracarboranylphenylporphyrins containing 40 or 80 boron atoms and their biological properties in EMT-6 tumor-bearing mice.
Wu H; Micca PL; Makar MS; Miura M
Bioorg Med Chem; 2006 Aug; 14(15):5083-92. PubMed ID: 16651000
[TBL] [Abstract][Full Text] [Related]
13. Towards new boron carriers for boron neutron capture therapy: metallacarboranes and their nucleoside conjugates.
Leśnikowski ZJ; Paradowska E; Olejniczak AB; Studzińska M; Seekamp P; Schüssler U; Gabel D; Schinazi RF; Plesek J
Bioorg Med Chem; 2005 Jul; 13(13):4168-75. PubMed ID: 15878666
[TBL] [Abstract][Full Text] [Related]
14. Novel boronated derivatives of 5,10,15,20-tetraphenylporphyrin: synthesis and toxicity for drug-resistant tumor cells.
Ol'shevskaya VA; Zaitsev AV; Luzgina VN; Kondratieva TT; Ivanov OG; Kononova EG; Petrovskii PV; Mironov AF; Kalinin VN; Hofmann J; Shtil AA
Bioorg Med Chem; 2006 Jan; 14(1):109-20. PubMed ID: 16185886
[TBL] [Abstract][Full Text] [Related]
15. In vitro neutron irradiation of glioma and endothelial cultured cells.
Menichetti L; Gaetano L; Zampolli A; Del Turco S; Ferrari C; Bortolussi S; Stella S; Altieri S; Salvadori PA; Cionini L
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S336-40. PubMed ID: 19410472
[TBL] [Abstract][Full Text] [Related]
16. Xylose as a carrier for boron containing compounds.
Jacobsson M; Winander C; Mani K; Ellervik U
Bioorg Med Chem Lett; 2008 Apr; 18(7):2451-4. PubMed ID: 18325767
[TBL] [Abstract][Full Text] [Related]
17. Cellular uptake of lipoproteins and persistent organic compounds--an update and new data.
Hjelmborg PS; Andreassen TK; Bonefeld-Jørgensen EC
Environ Res; 2008 Oct; 108(2):192-8. PubMed ID: 18762293
[TBL] [Abstract][Full Text] [Related]
18. Boronated protohaemins: synthesis and in vivo antitumour efficacy.
Ol'shevskaya VA; Nikitina RG; Zaitsev AV; Luzgina VN; Kononova EG; Morozova TG; Drozhzhina VV; Ivanov OG; Kaplan MA; Kalinin VN; Shtil AA
Org Biomol Chem; 2006 Oct; 4(20):3815-21. PubMed ID: 17024289
[TBL] [Abstract][Full Text] [Related]
19. Photophysics and intracellular distribution of a boronated porphyrin phototherapeutic agent.
Spizzirri PG; Hill JS; Kahl SB; Ghiggino KP
Photochem Photobiol; 1996 Dec; 64(6):975-83. PubMed ID: 8972641
[TBL] [Abstract][Full Text] [Related]
20. Cellular pharmacological properties of gold(III) porphyrin 1a, a potential anticancer drug lead.
Wang Y; He QY; Sun RW; Che CM; Chiu JF
Eur J Pharmacol; 2007 Jan; 554(2-3):113-22. PubMed ID: 17116302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
